Follow
Lisa D. Laury-Kleintop
Lisa D. Laury-Kleintop
Associate Professor, Lankenau Institute for Medical Research
Verified email at limr.org
Title
Cited by
Cited by
Year
Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2, 3-dioxygenase inhibitory compound D-1-methyl-tryptophan
R Metz, JB DuHadaway, U Kamasani, L Laury-Kleintop, AJ Muller, ...
Cancer research 67 (15), 7082-7087, 2007
5872007
Indoleamine 2, 3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer
GC Prendergast, C Smith, S Thomas, L Mandik-Nayak, L Laury-Kleintop, ...
Cancer immunology, immunotherapy 63, 721-735, 2014
5082014
IDO is a nodal pathogenic driver of lung cancer and metastasis development
C Smith, MY Chang, KH Parker, DW Beury, JB DuHadaway, HE Flick, ...
Cancer discovery 2 (8), 722-735, 2012
3342012
Inflammatory reprogramming with IDO1 inhibitors: turning immunologically unresponsive ‘cold’tumors ‘hot’
GC Prendergast, A Mondal, S Dey, LD Laury-Kleintop, AJ Muller
Trends in cancer 4 (1), 38-58, 2018
1442018
RhoB regulates PDGFR-β trafficking and signaling in vascular smooth muscle cells
M Huang, JB DuHadaway, GC Prendergast, LD Laury-Kleintop
Arteriosclerosis, thrombosis, and vascular biology 27 (12), 2597-2605, 2007
842007
Cholesterol, calcium and atherosclerosis: is there a role for calcium channel blockers in atheroprotection?
TN Tulenko, L Laury-Kleintop, MF Walter, RP Mason
International journal of cardiology 62, S55-S66, 1997
811997
The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells
S Trabanelli, D Očadlíková, M Ciciarello, V Salvestrini, M Lecciso, ...
The Journal of Immunology 192 (3), 1231-1240, 2014
722014
The exon-intron organization of the human erythrocyte α-spectrin gene
L Kotula, LD Laury-Kleintop, L Showe, K Sahr, AJ Linnenbach, B Forget, ...
Genomics 9 (1), 131-140, 1991
571991
Cardiac and gastrointestinal liabilities caused by deficiency in the immune modulatory enzyme indoleamine 2, 3-dioxygenase
MY Chang, C Smith, JB DuHadaway, JR Pyle, J Boulden, AP Soler, ...
Cancer biology & therapy 12 (12), 1050-1058, 2011
552011
IDO is a nodal pathogenic driver of lung cancer and metastasis development. Cancer Discov. 2012; 2: 722–735. doi: 10.1158/2159-8290
C Smith, MY Chang, KH Parker, DW Beury, JB DuHadaway, HE Flick, ...
CD-12-0014.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0
53
RhoB links PDGF signaling to cell migration by coordinating activation and localization of Cdc42 and Rac
M Huang, L Satchell, JB DuHadaway, GC Prendergast, ...
Journal of cellular biochemistry 112 (6), 1572-1584, 2011
472011
The smooth muscle cell membrane during atherogenesis: a potential target for amlodipine in atheroprotection
TN Tulenko, AE Sumner, M Chen, Y Huang, L Laury-Kleintop, ...
American Heart Journal 141 (2), S1-S11, 2001
472001
The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in apo E-/-mice
S Jacob, L Laury-Kleintop, S Lanza-Jacoby
Journal of Surgical Research 146 (1), 135-142, 2008
462008
Therapeutic antibody targeting of indoleamine-2, 3-dioxygenase (IDO2) inhibits autoimmune arthritis
LMF Merlo, S Grabler, JB DuHadaway, E Pigott, K Manley, ...
Clinical Immunology 179, 8-16, 2017
452017
Reduction of the expression of the late-onset Alzheimer’s disease (AD) risk-factor BIN1 does not affect amyloid pathology in an AD mouse model
RJ Andrew, P De Rossi, P Nguyen, HR Kowalski, AJ Recupero, ...
Journal of Biological Chemistry 294 (12), 4477-4487, 2019
432019
Discovery of a human peptide sequence signaling islet neogenesis
CS Levetan, LV Upham, S Deng, L Laury-Kleintop, V Kery, R Nolan, ...
Endocrine Practice 14 (9), 1075-1083, 2008
392008
Stromal cyclin D1 promotes heterotypic immune signaling and breast cancer growth
TG Pestell, X Jiao, M Kumar, AR Peck, M Prisco, S Deng, Z Li, A Ertel, ...
Oncotarget 8 (47), 81754, 2017
372017
Compartmentalization of hnRNP‐K during cell cycle progression and its interaction with calponin in the cytoplasm
LD Laury‐Kleintop, M Tresini, O Hammond
Journal of cellular biochemistry 95 (5), 1042-1056, 2005
372005
Suprabasal induction of ornithine decarboxylase in adult mouse skin is sufficient to activate keratinocytes
L Lan, CS Hayes, L Laury-Kleintop, SK Gilmour
Journal of investigative dermatology 124 (3), 602-614, 2005
352005
Celecoxib combined with atorvastatin prevents progression of atherosclerosis
M Raval, PG Frank, L Laury-Kleintop, G Yan, S Lanza-Jacoby
Journal of Surgical Research 163 (2), e113-e122, 2010
342010
The system can't perform the operation now. Try again later.
Articles 1–20